title: Pharmacokinetics and safety of combination therapy with lithium and risperidone.
authors.forename: J H
authors.initials: JH
authors.lastname: Demling
authors.forename: M-L
authors.initials: ML
authors.lastname: Huang
authors.forename: B
authors.initials: B
authors.lastname: Remmerie
authors.forename: E
authors.initials: E
authors.lastname: Mannaert
authors.forename: W
authors.initials: W
authors.lastname: Sperling
mesh_terms: D000293:Adolescent; D018692:Antimanic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019540:Area Under Curve; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008297:Male; D011618:Psychotic Disorders / Q000188:drug therapy / Q000523:psychology; D018967:Risperidone / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy
chemical_list: D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D018967:Risperidone